CVM Updates
FDA’s Center for Veterinary Medicine (CVM) issues CVM Updates on topics of interest to our stakeholders. These brief news releases provide the public with relevant and timely information about FDA and animal health. You can receive CVM Updates by subscribing to our automated e-mail distribution list. Please click on the link below to subscribe.
Latest Update
December
- December 14, 2022 - FDA Opens Registration for Virtual Public Meeting on FDA’s Role in the AAFCO Animal Feed Ingredient Definition Process
- December 13, 2022 - FDA Animal Drug Safety Communication: Micotil 300 Labeling Change
- December 13, 2022 - Updated - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status
- December 12, 2022 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2021 for Use in Food-Producing Animals
- December 8, 2022 - FDA Approves First Oral Treatment for Cats with Diabetes Mellitus
- December 7, 2022 - FDA Opens Second FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
November
- November 29, 2022 - FDA Announces Draft Guidance for Heartworm Disease Prevention Products for Dogs
- November 29, 2022 - FDA Launches Interactive Summary of Biomass-Adjusted Antimicrobial Sales Data in Food Animals
- November 18, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Drug User Fee Program
- November 16, 2022 - FDA Releases Draft Amended Environmental Assessment for AquAdvantage Salmon and Announces Virtual Public Meeting
- November 15, 2022 - FDA Conditionally Approves First Drug to Manage Acute Onset of Pancreatitis in Dogs
October
- October 20, 2022 - FDA Issues Final Guidance on Refusal of Inspection by a Foreign Food Establishment or Foreign Government
- October 19, 2022 - FDA Finalizes Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals
- Updated October 19, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
- Updated October 18, 2022 - FDA Helps Improve Availability of Vetmedin, a Critical Heart Drug for Dogs, in the United States
- Updated October 18, 2022 - FDA Explains Revised Submission Process for U.S. Animal Feed Additive, Premix, and Compound Feed Facilities Interested in Exporting to China
- Updated October 12, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
- October 12, 2022 - FDA Announces 2022 Public Meeting and Comment Period on Reauthorization of Animal Generic Drug User Fee Program
September
- September 30, 2022 - FDA Reminds Human and Animal Food Facilities to Register or Renew Registration between October 1 and December 31, 2022
- September 29, 2022 - FDA Approves First Generic Spectinomycin Sulfate Injectable for Treatment of Bovine Respiratory Disease (Español)
- September 28, 2022 - FDA Approves Simplera Otic Solution to Treat Ear Infections in Dogs (Español)
- September 14, 2022 - FDA Provides for More Treatments for Dogs and Cats to Qualify for Minor Use Status
- September 7, 2022 - CVM Drug Safety Communication: Fluorouracil Products Used on People's Skin Can Cause Serious Reactions in Pets (Español)
August
- August 30, 2022 - FDA Announces Virtual Listening Session on the Regulation of Animal Foods with Certain Types of Claims
- August 11, 2022 - FDA Seeks Public Comment on Revised Guidance Documents Focused on Harmonizing Requirements for Anti-parasitic Drugs Used in Animals
- August 10, 2022 - FDA Releases FY 2020 Pesticide Residue Monitoring Report
- August 1, 2022 - FDA Approves the First Generic Firocoxib Tablets for Horses (Español)
July
- July 27, 2022 - FDA Announces FY 2023 Animal Drug User Fee Rates for ADUFA and AGDUFA
- July 25, 2022 - FDA Withdraws Guidance on Indexing of Legally Marketed Unapproved New Animal Drugs for Minor Species (Español)
- July 22, 2022 - Food Facilities Invited to Join “How To” Webinar on Registration and Renewal as Biennial Food Facility Registration Period Approaches
- July 6, 2022 - FDA Finalizes FSMA Guidance on Hazard Analysis and Preventive Controls for Animal Food (Español)
- July 5, 2022 - FDA Announces 2022 Public Meeting of the National Antimicrobial Resistance Monitoring System
June
- June 30, 2022 - FDA Delivers Progress Update on 5-Year Veterinary Stewardship Plan, Publishes Report about Antimicrobial Sales, Use, and Resistance Data in Animal Agriculture (Español)
- June 27, 2022 - FDA Announces Virtual Public Meeting on Advanced Manufacturing for Animal Drugs
- June 27, 2022 - FDA Announces Animal Biotechnology Webinar on Low-Risk Intentional Genomic Alterations in Animals for Food Use (Español)
- June 24, 2022 - FDA Recognizes JANAAC as an Accreditation Body Under FSMA- Accredited Third Party Certification Program
- June 16, 2022 - FDA Conditionally Approves First Drug to Delay Onset of Congestive Heart Failure in Dogs (Español)
- June 10, 2022 - Updated - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals
- June 6, 2022 - FDA Announces Live Webinar on the Animal Drug Manufacturing System for Reporting Supply Chain Data
- June 6, 2022 - FDA Releases New Resource Page for Human and Animal Food Producers Affected by Flooding and Severe Weather Incidents
May
- May 31, 2022 - FDA Opens First FY2023 Grant Funding Application Period for Animal Drugs for Minor Uses and Minor Species
- May 26, 2022 - FDA Warns Four Companies for Illegally Selling CBD Products Intended for Use in Food-Producing Animals
- May 23, 2022 - FDA Shares New Report by Reagan-Udall Foundation on Establishing Public-Private Partnership to Collect and Analyze Antimicrobial Use Data from Food-Producing Animals
- May 9, 2022 - FDA Issues Draft Guidance that Consolidates and Updates Policies on Practices to Prevent Contamination of Animal Food from Unsafe Drug Carryover (Español)
April
- April 28, 2022 - FDA Issues the Accredited Third-Party Certification Program: Questions and Answers: Draft Guidance for Industry
- April 27, 2022 - FDA Issues Updated Guidance on Compliance and Date for Providing an Acceptable Unique Facility Identifier (DUNS number) for the Foreign Supplier Verification Programs
- April 19, 2022 - FDA Releases NARMS Integrated Summary 2019
- April 19, 2022 - FDA Announces Draft Guidance for the Use of Published Literature to Support New Animal Drug Approvals (Español)
- April 13, 2022 - FDA Issues Final Guidance on Animal Drug Compounding from Bulk Drug Substances
March
- March 30, 2022 - FDA Approves New Combination Drug for Sedation in Dogs (Español)
- March 30, 2022 - Updated - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
- March 28, 2022 - Updated - FDA Advises Companies Regarding Inadvertent Presence of Low Levels of Certain Genetically Engineered Canola Seeds
- March 28, 2022 - FDA Approves the First Generic Firocoxib Chewable Tablets for Dogs (Español)
- March 11, 2022 - FDA Issues Guidance on Enforcement Discretion Policies for Certain FSMA Regulations
- March 7, 2022 - FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review
February
- February 28, 2022 - FDA Veterinarians Contribute One Health Resource on Global Antiparasitic Resistance in Grazing Livestock
- February 15, 2022 - FDA Requests Public Comments on the Use of Antimicrobials in Companion Animals (Español)
January
- January 25, 2022 - FDA Approves First Generic Tilmicosin Phosphate Aqueous Concentrate for Swine (Español)
- January 21, 2022 - FDA Announces Two Veterinary Antimicrobial Stewardship Funding Opportunities for FY 2022 (Español)
- January 20, 2022 - FDA Approves First Transdermal Buprenorphine for the Control of Post-Surgical Pain in Cats (Español)
- January 13, 2022 - FDA Approves Novel Treatment to Control Pain in Cats with Osteoarthritis, First Monoclonal Antibody Drug for Use in Any Animal Species
- January 12, 2022 - FDA Announces Public Hearing on Scientific Data and Information Related to the Residue of Carcinogenic Concern for the New Animal Drug Carbadox
December
- December 21, 2021 - FDA Conditionally Approves First Oral Tablet to Treat Chemotherapy-Induced Diarrhea in Dogs
- December 20, 2021 - FDA Announces eSubmitter Update to Enhance Monitoring of Animal Drug Supply Chain
- December 14, 2021 - FDA Releases Annual Summary Report on Antimicrobials Sold or Distributed in 2020 for Use in Food-Producing Animals
- December 3, 2021 - FDA Opens Second Grant Funding Application Period for FY2022 for Animal Drugs for Minor Uses and Minor Species
- December 2, 2021 - FDA Asks Reagan-Udall Foundation to Gather Stakeholder Feedback About Collection of Antimicrobial-Use Data in Food Animals
- December 1, 2021 - FDA Issues Final Rule for Laboratory Accreditation for Analyses of Foods
October
- October 20, 2021 - FY 2019 Pesticide Report: Consistent with Trends Over the Past 8 Years, Pesticide Residue Levels Remain Low
- October 20, 2021 - Updated - FDA Announces Webinar on the Development of Animal Cells, Tissues, and Cell- and Tissue-based Products
- October 5, 2021 - Updated - FDA Issues Guidances to Help Facilitate the Development of New Animal Drug Submissions
- October 4, 2021 - FDA Announces Webinar on the Development of Animal Cells, Tissues, and Cell- and Tissue-based Products
September
- September 27, 2021 - FDA and United Kingdom Announce Mutual Recognition Agreement for Pharmaceutical Good Manufacturing Practice Inspections of Animal Drugs
- September 22, 2021 - FDA Issues Draft Guidance on Donor Eligibility and Manufacturing of Cellular Therapies for Animals
- September 7, 2021 - FDA to Participate in National Institutes of Health 2021 Pain in Animals Workshop
August
- August 27, 2021 - Resources for Animal Food Producers in the Gulf Coast of the United States Affected by Tropical Storm Ida (Español)
- August 19, 2021 - FDA Approves First Generic Amoxicillin and Clavulanate Potassium for Oral Suspension for Use in Cats and Dogs
- August 11, 2021 - FDA to Host Virtual Listening Session on the Oversight of Pet Food
July
- July 27, 2021 - FDA Announces FY 2022 Animal Drug User Fee Rates for ADUFA and AGDUFA
- July 15, 2021 - FDA Grants First Full Approval for Treatment of Lymphoma in Dogs
- July 15, 2021 - FDA Launches Resource to Increase Awareness of Animal Drug Safety-Related Labeling Changes
- July 13, 2021 - Updated - FDA Issues Final Guidance on Expanded Conditional Approval for Certain Animal Drugs
- July 6, 2021 - Resources for Animal Food Producers in the Southeastern United States Affected by Tropical Storm Elsa (Español)
June
- June 23, 2021 - FDA Requests Comment on Eligibility for Indexing of Unapproved Animal Drugs
- June 21, 2021 - Resources for Animal Food Producers in the Southeastern United States Affected by Tropical Storm Claudette (Español)
- June 10, 2021 - FDA Finalizes Guidance to Bring Remaining Approved Over-The-Counter Medically Important Antimicrobial Drugs Used for Animals Under Veterinary Oversight
- June 7, 2021 - FDA Explains Revised Submission Process for U.S. Animal Feed Additive, Premix, and Compound Feed Facilities Interested in Exporting to China
May
- May 28, 2021 - FDA Opens First Grant Funding Application Period for FY2022 for Animal Drugs for Minor Uses and Minor Species
- May 20, 2021 - Updated - FDA Issues Draft Guidance on Demonstrating Bioequivalence for Soluble Powder Animal Drugs
- May 12, 2021 - FDA Helps Improve Availability of Vetmedin, a Critical Heart Drug for Dogs, in the United States
- May 10, 2021 - FDA Announces Animal Biotechnology Stakeholder Virtual Outreach Session
- May 10, 2021 - FDA Opens Industry Portal for FSVP Records Submission
April
- April 13, 2021 - FDA Advises Companies Regarding Inadvertent Presence of Low Levels of Certain Genetically Engineered Canola Seeds
- April 9, 2021 - Updated - FDA Holds Virtual Public Meeting to Discuss Potential Approach for Ranking of Antimicrobial Drugs According to Their Importance in Human Medicine: A Risk Management Tool for Antimicrobial Animal Drugs
- April 6, 2021 - FDA Announces Improved Performance Measure Dashboards for Animal Drug and Food Key Initiatives
March
- March 30, 2021 - FDA Extends Flexibility for Unique Facility Identifier Requirement for Food Facility Registration through December 2022
- March 23, 2021 - FDA Approves First Generic Ketoprofen for Use in Horses
February
- February 22, 2021 - Updated - FDA Seeks Public Comment on Potential Approach for Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals
- February 19, 2021 - FDA Approves First Generic Tulathromycin Products for Treating Disease in Certain Cattle and Swine
- February 8, 2021 - FDA Announces New Resource for Veterinarians and Pet Owners Interested in Clinical Field Studies of Animal Cells, Tissues, and Cell- and Tissue-Based Products
January
- January 15, 2021 - FDA Approves ThyroKare (levothyroxine sodium tablets) for Replacement Therapy for Diminished Thyroid Function in Dogs
- January 14, 2021 - FDA Grants First Conditional Approval Under Expanded Authority to Control Seizures in Dogs with Idiopathic Epilepsy
- January 11, 2021 - FDA Conditionally Approves First Oral Tablet to Treat Lymphoma in Dogs
- January 8, 2021 - FDA Seeks Public Comment on Potential Approach for Defining Durations of Use for Certain Medically Important Antimicrobial Drugs for Food Animals